HeyJaredJessica Jani
- Indexed articles, last 90 days
- 25
- Latest publication
- Sep 14, 2026
- Outlet visibility, for Livemint
- Top 10K sites
- Earliest in this view
- Jul 7, 2026
Latest articles
Mint Explainer | Why counterfeit drugs are getting harder to detect in India | Mint (opens the original)
Read excerpt
This is a Mint Premium article gifted to you.Subscribe to enjoy similar stories. Two major instances of counterfeit life-saving drugs being uncovered in the past two weeks have raised concern among consumers. Industry executives say counterfeiting is a growing challenge, with fake drugs becoming harder to detect even as authorities try to crack the networks. Mint explains what is driving the problem, its impact on consumers and the regulatory response. On 13 September, a special investigation te
W Health Ventures closes Fund II at ₹700 crore, aims to build 8-10 healthcare startups | Company Business News (opens the original)
Read excerpt
This is a Mint Premium article gifted to you.Subscribe to enjoy similar stories. Healthcare investment firm W Health Ventures announced the final close of its oversubscribed Fund II at ₹700 crore on Tuesday, beating its initial target of ₹630 crore. According to managing partner Pankaj Jethwani, Fund II will target large problems within niche markets across oncology, preventive health, geriatrics and pain management. He added that W Health Ventures, which is India’s first healthcare company crea
PI Industries bets on innovation-led growth as agrochem headwinds mount | Company Business News (opens the original)
Read excerpt
This is a Mint Premium article gifted to you.Subscribe to enjoy similar stories. Amid a challenging global environment, agrochemical major PI Industries is betting on novel molecules developed in-house and is branching out into manufacturing capabilities for pharmaceuticals, speciality chemicals, and electronics to fuel long-term growth. “We are an 80-year-old organisation, I do believe after a certain scale and size in the world today, innovation creates moats…it's a call of risk and an appetit
Sun Pharma signs deal with US government to reduce drug prices | Company Business News (opens the original)
Read excerpt
Drug major Sun Pharmaceutical Industries has signed a deal with the US government to lower prices of its innovative drugs in the US, in line with the lowest prices paid by other developed nations, under the most favoured nation (MFN) pricing framework. It has also committed to applying MFN pricing to future innovative medicine launches, the company said on Tuesday. Under the agreement, Sun Pharma will also avoid tariffs on innovative pharmaceutical products for more than two years. The drugmaker
Natco Pharma looks beyond generics for its next growth shot | Company Business News (opens the original)
Read excerpt
This is a Mint Premium article gifted to you.Subscribe to enjoy similar stories. Natco Pharma has built its business around a familiar playbook for years: cracking complex and difficult-to-make generics that can deliver outsized earnings if they succeed. But as competition intensifies and the growth in generics stalls, the Hyderabad-based company is looking beyond the US, its key market, to broaden its bets, both geographically and further up the value chain. The mid-sized drugmaker, known for i
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 10K sites
For Livemint, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.